7.99% -2.86

Stoke Therapeutics Inc (STOK)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Stoke Therapeutics Inc-Aktie (STOK)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	23.05% 10.63	13.82	158.57	22.61	4.894
Operating Expenses	30.66% 53.72	41.12	47.33	36.27	34.90
Interest Income/Expense	0.00% 0.003	0.003	0.001	-	-
Benefits Costs and Expenses	34.74% 50.26	37.30	44.41	33.10	-
Costs And Expenses	34.74% 50.26	37.30	44.41	33.10	34.90
Operating Income/Loss	57.84% -43.09	-27.30	111.24	-13.65	-30.00
Nonoperating Income/Loss	9.20% 3.466	3.817	2.917	3.171	3.573
Income/Loss From Continuing Operations Before Tax	68.74% -39.62	-23.48	114.16	-10.48	4.894
Income Tax Expense/Benefit	-1.278	-	1.278	-	-
Income/Loss From Continuing Operations After Tax	63.30% -38.35	-23.48	112.88	-10.48	-26.43
Net Income/Loss	63.30% -38.35	-23.48	112.88	-10.48	-26.43
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.44% 58.61	58.35	57.86	1.0179	56.34
Diluted Average Shares	0.44% 58.61	58.35	59.40	1.0179	56.34
Basic Earnings Per Share	62.50% -0.65	-0.40	1.95	-0.17	-0.47
Diluted Earnings Per Share	62.50% -0.65	-0.40	1.90	-0.17	-0.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%